European Society of Human Genetics reprimands Myriad on patent secrets

ESHG

The European Society of Human Genetics policy committee has chastised Myriad Genetics for refusing to share its patented genetic database on the grounds that the information is commercially sensitive.

 While Myriad primarily uses its patented BRCA genetic test to look for cancer-causing mutations, it has also used the test to compile a database of “variants of unknown significance” which some scientists, activists and lawyers argue argue should be released because they could facilitate other research.

View the original article here: European Society of Human Genetics reprimands Myriad Genetics on patent secrets

 

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
seralinistud

Gilles-Éric Séralini: Activist professor and face of anti-GMO industry

The French biologist and his research team--funded by the Rodale ...
vandana shiva

Vandana Shiva: ‘Rock Star’ of GMO protest movement has anti-science history

In a 2012 interview, Bill Moyers referred to Vandana Shiva as ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend